News
Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns
Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...
WHAT should’ve been an ordinary morning for Tashana Easy turned into a life-altering day after her vision became blurry and ...
We entered into a new position in KITS Eyecare, which I've followed since their IPO in 2021. Click here for our KTYCF / ...
Polarized glasses with smoke or gray lenses may offer the best protection against the sun's rays and reduce glare. Warby ...
Specsavers surpasses 150 stores in Canada, aiming to reach 1 million patients by 2025 with a focus on affordability, quality, ...
That said, most doctors generally look for certain indicators that someone has a higher likelihood of doing well after ...
We do not see JD Health to be in any financial distress. The balance sheet has CNY 200 million of debt compared with CNY 40 billion of cash and equivalents and almost no debt as of Dec. 31, 2024. The ...
In a significant development for paediatric eye care, India has become the first country to approve a new formulation of eye drops ...
While not as popular as traditional glasses, contact lenses have distinct advantages for eye health and several innovations that benefit wearers. Consider the following to make an informed decision ...
“Contact lenses are a convenient alternative to spectacles, particularly for individuals who want to avoid surgery and wearing spectacles, but they come with their own set of risks. Wearing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results